Comparative Effectiveness of a Web-Based Patient Decision Aid for Therapeutic Options for Sickle Cell Disease: Randomized Controlled Trial

Lakshmanan Krishnamurti, Diana Ross, Cynthia Sinha, Traci Leong, Namita Bakshi, Nonita Mittal, Divya Veludhandi, Anh-Phuong Pham, Alankrita Taneja, Kamesh Gupta, Julum Nwanze, Andrea Marie Matthews, Saumya Joshi, Veronica Vazquez Olivieri, Santhi Arjunan, Ifechi Okonkwo, Ines Lukombo, Peter Lane, Nitya Bakshi, George Loewenstein, Lakshmanan Krishnamurti, Diana Ross, Cynthia Sinha, Traci Leong, Namita Bakshi, Nonita Mittal, Divya Veludhandi, Anh-Phuong Pham, Alankrita Taneja, Kamesh Gupta, Julum Nwanze, Andrea Marie Matthews, Saumya Joshi, Veronica Vazquez Olivieri, Santhi Arjunan, Ifechi Okonkwo, Ines Lukombo, Peter Lane, Nitya Bakshi, George Loewenstein

Abstract

Background: Hydroxyurea, chronic blood transfusions, and bone marrow transplantation are efficacious, disease-modifying therapies for sickle cell disease but involve complex risk-benefit trade-offs and decisional dilemma compounded by the lack of comparative studies. A patient decision aid can inform patients about their treatment options, the associated risks and benefits, help them clarify their values, and allow them to participate in medical decision making.

Objective: The objective of this study was to develop a literacy-sensitive Web-based patient decision aid based on the Ottawa decision support framework, and through a randomized clinical trial estimate the effectiveness of the patient decision aid in improving patient knowledge and their involvement in decision making.

Methods: We conducted population decisional needs assessments in a nationwide sample of patients, caregivers, community advocates, policy makers, and health care providers using qualitative interviews to identify decisional conflict, knowledge and expectations, values, support and resources, decision types, timing, stages and learning, and personal clinical characteristics. Interview transcripts were coded using QSR NVivo 10. Alpha testing of the patient decision aid prototype was done to establish usability and the accuracy of the information it conveyed, and then was followed by iterative cycles of beta testing. We conducted a randomized clinical trial of adults and of caregivers of pediatric patients to evaluate the efficacy of the patient decision aid.

Results: In a decisional needs assessment, 223 stakeholders described their preferences, helping to guide the development of the patient decision aid, which then underwent alpha testing by 30 patients and 38 health care providers and iterative cycles of beta testing by 87 stakeholders. In a randomized clinical trial, 120 participants were assigned to either the patient decision aid or standard care (SC) arm. Qualitative interviews revealed high levels of usability, acceptability, and utility of the patient decision aid in education, values clarification, and preparation for decision making. On the acceptability survey, 72% (86/120) of participants rated the patient decision aid as good or excellent. Participants on the patient decision aid arm compared to the SC arm demonstrated a statistically significant improvement in decisional self-efficacy (P=.05) and a reduction in the informed sub-score of decisional conflict (P=.003) at 3 months, with an improvement in preparation for decision making (P<.001) at 6 months. However, there was no improvement in terms of the change in knowledge, the total or other domain scores of decisional conflicts, or decisional self-efficacies at 6 months. The large amount of missing data from survey completion limited our ability to draw conclusions about the effectiveness of the patient decision aid. The patient decision aid met 61 of 62 benchmarks of the international patient decision aid collaboration standards for content, development process, and efficacy.

Conclusions: We have developed a patient decision aid for sickle cell disease with extensive input from stakeholders and in a randomized clinical trial demonstrated its acceptability and utility in education and decision making. We were unable to demonstrate its effectiveness in improving patient knowledge and involvement in decision making.

Trial registration: ClinicalTrials.gov NCT03224429; https://ichgcp.net/clinical-trials-registry/NCT03224429 and ClinicalTrials.gov NCT02326597; https://ichgcp.net/clinical-trials-registry/NCT02326597.

Keywords: decision aids; decision support; sickle cell anemia; sickle cell disease; sickle cell disorders.

Conflict of interest statement

Conflicts of Interest: None declared.

©Lakshmanan Krishnamurti, Diana Ross, Cynthia Sinha, Traci Leong, Namita Bakshi, Nonita Mittal, Divya Veludhandi, Anh-Phuong Pham, Alankrita Taneja, Kamesh Gupta, Julum Nwanze, Andrea Marie Matthews, Saumya Joshi, Veronica Vazquez Olivieri, Santhi Arjunan, Ifechi Okonkwo, Ines Lukombo, Peter Lane, Nitya Bakshi, George Loewenstein. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 04.12.2019.

Figures

Figure 1
Figure 1
The iterative process for the development and testing of the patient decision aid using the Ottawa decisional framework.
Figure 2
Figure 2
Consort diagram describing the recruitment in the randomized clinical trial. PtDA: patient decision aid.

References

    1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010 Apr;38(4 Suppl):S512–21. doi: 10.1016/j.amepre.2009.12.022.
    1. Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) 2005 Nov;84(6):363–76.
    1. Okam MM, Shaykevich S, Ebert BL, Zaslavsky AM, Ayanian JZ. National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008. Med Care. 2014 Jul;52(7):612–8. doi: 10.1097/MLR.0000000000000143.
    1. McCavit TL, Xuan L, Zhang S, Flores G, Quinn CT. National trends in incidence rates of hospitalization for stroke in children with sickle cell disease. Pediatr Blood Cancer. 2013 May;60(5):823–7. doi: 10.1002/pbc.24392.
    1. Panepinto JA, Bonner M. Health-related quality of life in sickle cell disease: past, present, and future. Pediatr Blood Cancer. 2012 Aug;59(2):377–85. doi: 10.1002/pbc.24176.
    1. Palermo TM, Riley CA, Mitchell BA. Daily functioning and quality of life in children with sickle cell disease pain: relationship with family and neighborhood socioeconomic distress. J Pain. 2008 Sep;9(9):833–40. doi: 10.1016/j.jpain.2008.04.002.
    1. McClish DK, Penberthy LT, Bovbjerg VE, Roberts JD, Aisiku IP, Levenson JL, Roseff SD, Smith WR. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes. 2005 Aug 29;3:50. doi: 10.1186/1477-7525-3-50.
    1. Dampier C, LeBeau P, Rhee S, Lieff S, Kesler K, Ballas S, Rogers Z, Wang W, Comprehensive Sickle Cell Centers (CSCC) Clinical Trial Consortium (CTC) Site Investigators Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium. Am J Hematol. 2011 Feb;86(2):203–5. doi: 10.1002/ajh.21905. doi: 10.1002/ajh.21905.
    1. Dale JC, Cochran CJ, Roy L, Jernigan E, Buchanan GR. Health-related quality of life in children and adolescents with sickle cell disease. J Pediatr Health Care. 2011;25(4):208–15. doi: 10.1016/j.pedhc.2009.12.006.
    1. Bonner MJ. Health related quality of life in sickle cell disease: just scratching the surface. Pediatr Blood Cancer. 2010 Jan;54(1):1–2. doi: 10.1002/pbc.22301.
    1. Barakat LP, Patterson CA, Daniel LC, Dampier C. Quality of life among adolescents with sickle cell disease: mediation of pain by internalizing symptoms and parenting stress. Health Qual Life Outcomes. 2008;6:60. doi: 10.1186/1477-7525-6-60.
    1. Adeyemo TA, Ojewunmi OO, Diaku-Akinwumi IN, Ayinde OC, Akanmu AS. Health related quality of life and perception of stigmatisation in adolescents living with sickle cell disease in Nigeria: A cross sectional study. Pediatr Blood Cancer. 2015 Jul;62(7):1245–51. doi: 10.1002/pbc.25503.
    1. Bediako SM. Predictors of employment status among African Americans with sickle cell disease. J Health Care Poor Underserved. 2010 Nov;21(4):1124–37. doi: 10.1353/hpu.2010.0945.
    1. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994 Jun 9;330(23):1639–44. doi: 10.1056/NEJM199406093302303.
    1. Lanzkron S, Carroll CP, Haywood C. Mortality rates and age at death from sickle cell disease: U.S., 1979-2005. Public Health Rep. 2013;128(2):110–6. doi: 10.1177/003335491312800206.
    1. Hamideh D, Alvarez O. Sickle cell disease related mortality in the United States (1999-2009) Pediatr Blood Cancer. 2013 Sep;60(9):1482–6. doi: 10.1002/pbc.24557.
    1. Darbari DS, Wang Z, Kwak M, Hildesheim M, Nichols J, Allen D, Seamon C, Peters-Lawrence M, Conrey A, Hall MK, Kato GJ, Taylor JG. Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study. PLoS One. 2013;8(11):e79923. doi: 10.1371/journal.pone.0079923.
    1. Ojodu J, Hulihan MM, Pope SN, Grant AM. Incidence of sickle cell trait--United States, 2010. MMWR Morb Mortal Wkly Rep. 2014 Dec 12;63(49):1155–8.
    1. Haywood C, Beach MC, Lanzkron S, Strouse JJ, Wilson R, Park H, Witkop C, Bass EB, Segal JB. A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. J Natl Med Assoc. 2009 Oct;101(10):1022–33. doi: 10.1016/s0027-9684(15)31069-5.
    1. Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi CE, James AH, Laraque D, Mendez MH, Montoya CJ, Pollock BH, Robinson L, Scholnik AP, Schori M. NIH consensus development statement on hydroxyurea treatment for sickle cell disease. NIH Consens State Sci Statements. 2008;25(1):1–30.
    1. Charache S, Dover GJ, Moyer MA, Moore JW. Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. Blood. 1987 Jan;69(1):109–16.
    1. Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV, Barredo JC, Brown RC, Sarnaik SA, Howard TH, Wynn LW, Kutlar A, Armstrong FD, Files BA, Goldsmith JC, Waclawiw MA, Huang X, Thompson BW. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) Lancet. 2011 May 14;377(9778):1663–72. doi: 10.1016/S0140-6736(11)60355-3.
    1. Brandow AM, Jirovec DL, Panepinto JA. Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization. Am J Hematol. 2010 Aug;85(8):611–3. doi: 10.1002/ajh.21749. doi: 10.1002/ajh.21749.
    1. Thornburg CD, Calatroni A, Telen M, Kemper AR. Adherence to hydroxyurea therapy in children with sickle cell anemia. J Pediatr. 2010 Mar;156(3):415–9. doi: 10.1016/j.jpeds.2009.09.044.
    1. Lanzkron S, Haywood C, Hassell KL, Rand C. Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network. J Natl Med Assoc. 2008 Aug;100(8):968–73.
    1. Zumberg MS, Reddy S, Boyette RL, Schwartz RJ, Konrad TR, Lottenberg R. Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists. Am J Hematol. 2005 Jun;79(2):107–13. doi: 10.1002/ajh.20353. doi: 10.1002/ajh.20353.
    1. Patel NG, Lindsey T, Strunk RC, DeBaun MR. Prevalence of daily medication adherence among children with sickle cell disease: a 1-year retrospective cohort analysis. Pediatr Blood Cancer. 2010 Sep;55(3):554–6. doi: 10.1002/pbc.22605.
    1. Arnold SD, Bhatia M, Horan J, Krishnamurti L. Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches. Br J Haematol. 2016 Aug;174(4):515–25. doi: 10.1111/bjh.14167.
    1. Hansbury EN, Schultz WH, Ware RE, Aygun B. Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions. Pediatr Blood Cancer. 2012 Apr;58(4):611–5.
    1. Jae GA, Lewkowitz AK, Yang JC, Shen L, Rahman A, Del Toro G. Barriers to conceiving sibling donors for sickle cell disease: perspectives from patients and parents. Ethn Health. 2011;16(4-5):431–45. doi: 10.1080/13557858.2011.558619.
    1. Chou ST. Transfusion therapy for sickle cell disease: a balancing act. Hematology Am Soc Hematol Educ Program. 2013;2013:439–46. doi: 10.1182/asheducation-2013.1.439.
    1. Greenway A, Ware RE, Thornburg CD. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload. Am J Hematol. 2011 Apr;86(4):357–61. doi: 10.1002/ajh.21986. doi: 10.1002/ajh.21986.
    1. Wang WC, Dwan K. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. Cochrane Database Syst Rev. 2013 Nov 14;(11):CD003146. doi: 10.1002/14651858.CD003146.pub2.
    1. Wang WC. Central nervous system complications of sickle cell disease in children: an overview. Child Neuropsychol. 2007 Mar;13(2):103–19. doi: 10.1080/09297040600788136.
    1. Hankins J, Hinds P, Day S, Carroll Y, Li C, Garvie P, Wang W. Therapy preference and decision-making among patients with severe sickle cell anemia and their families. Pediatr Blood Cancer. 2007 Jun 15;48(7):705–10. doi: 10.1002/pbc.20903.
    1. Haywood C, Beach MC, Bediako S, Carroll CP, Lattimer L, Jarrett D, Lanzkron S. Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease. Am J Hematol. 2011 Jan;86(1):85–7. doi: 10.1002/ajh.21883. doi: 10.1002/ajh.21883.
    1. O'Connor AM, Bennett C, Stacey D, Barry MJ, Col NF, Eden KB, Entwistle V, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner DR. Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making. 2007;27(5):554–74. doi: 10.1177/0272989X07307319.
    1. O'Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, Entwistle VA, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner D. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009;(3):CD001431. doi: 10.1002/14651858.CD001431.pub2.
    1. O'Connor AM, Rostom A, Fiset V, Tetroe J, Entwistle V, Llewellyn-Thomas H, Holmes-Rovner M, Barry M, Jones J. Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ. 1999 Sep 18;319(7212):731–4.
    1. O'Connor AM, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, Holmes-Rovner M, Tait V, Tetroe J, Fiset V, Barry M, Jones J. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2003;(2):CD001431. doi: 10.1002/14651858.CD001431.
    1. Sickle Options Inc. SICKLE OPTIONS. Atlanta, GA: Sickle Options Inc; 2014. [2019-05-22].
    1. Elwyn G, O'Connor AM, Bennett C, Newcombe RG, Politi M, Durand M, Drake E, Joseph-Williams N, Khangura S, Saarimaki A, Sivell S, Stiel M, Bernstein SJ, Col N, Coulter A, Eden K, Härter M, Rovner MH, Moumjid N, Stacey D, Thomson R, Whelan T, van DWT, Edwards A. Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi) PLoS One. 2009 Mar;4(3):e4705. doi: 10.1371/journal.pone.0004705.
    1. Holmes-Rovner M, Nelson WL, Pignone M, Elwyn G, Rovner DR, O'Connor AM, Coulter A, Correa-de-Araujo R. Are patient decision aids the best way to improve clinical decision making? Report of the IPDAS Symposium. Med Decis Making. 2007;27(5):599–608. doi: 10.1177/0272989X07307272.
    1. Holmes-Rovner M. International Patient Decision Aid Standards (IPDAS): beyond decision aids to usual design of patient education materials. Health Expect. 2007 Jun;10(2):103–7. doi: 10.1111/j.1369-7625.2007.00445.x.
    1. Malterud K, Siersma VD, Guassora AD. Sample Size in Qualitative Interview Studies: Guided by Information Power. Qual Health Res. 2015 Nov 27;:1753–1760. doi: 10.1177/1049732315617444.
    1. Joseph-Williams N, Newcombe R, Politi M, Durand M, Sivell S, Stacey D, O'Connor A, Volk RJ, Edwards A, Bennett C, Pignone M, Thomson R, Elwyn G. Toward Minimum Standards for Certifying Patient Decision Aids: A Modified Delphi Consensus Process. Med Decis Making. 2014 Aug;34(6):699–710. doi: 10.1177/0272989X13501721.
    1. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, Thomson R, Barratt A, Barry M, Bernstein S, Butow P, Clarke A, Entwistle V, Feldman-Stewart D, Holmes-Rovner M, Llewellyn-Thomas H, Moumjid N, Mulley A, Ruland C, Sepucha K, Sykes A, Whelan T, International PDAS(C. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006 Aug 26;333(7565):417. doi: 10.1136/.
    1. Elwyn G, O'Connor AM, Bennett C, Newcombe RG, Politi M, Durand M, Drake E, Joseph-Williams N, Khangura S, Saarimaki A, Sivell S, Stiel M, Bernstein SJ, Col N, Coulter A, Eden K, Härter M, Rovner MH, Moumjid N, Stacey D, Thomson R, Whelan T, van DWT, Edwards A. Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi) PLoS One. 2009;4(3):e4705. doi: 10.1371/journal.pone.0004705.
    1. Joseph-Williams N, Newcombe R, Politi M, Durand M, Sivell S, Stacey D, O'Connor A, Volk RJ, Edwards A, Bennett C, Pignone M, Thomson R, Elwyn G. Toward Minimum Standards for Certifying Patient Decision Aids: A Modified Delphi Consensus Process. Med Decis Making. 2014 Aug;34(6):699–710. doi: 10.1177/0272989X13501721.
    1. Elwyn Glyn, O'Connor Annette M, Bennett Carol, Newcombe Robert G, Politi Mary, Durand Marie-Anne, Drake Elizabeth, Joseph-Williams Natalie, Khangura Sara, Saarimaki Anton, Sivell Stephanie, Stiel Mareike, Bernstein Steven J, Col Nananda, Coulter Angela, Eden Karen, Härter Martin, Rovner Margaret Holmes, Moumjid Nora, Stacey Dawn, Thomson Richard, Whelan Tim, van der Weijden Trudy, Edwards Adrian. Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi) PLoS One. 2009;4(3):e4705. doi: 10.1371/journal.pone.0004705.
    1. User Manual-Acceptability. 1996. [2019-05-22]. Connor AM, Cranney A .
    1. O'Connor AM. [2019-05-22]. User Manual-Values2004 09/30/2017 cited 2017 September 30 .
    1. O'Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G, McPherson R, Drake E, Hopman W, Mackenzie T. Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy. Med Decis Making. 1998;18(3):295–303. doi: 10.1177/0272989X9801800307.
    1. O'Connor AM, Wells GA, Tugwell P, Laupacis A, Elmslie T, Drake E. The effects of an 'explicit' values clarification exercise in a woman's decision aid regarding postmenopausal hormone therapy. Health Expect. 1999 Mar;2(1):21–32. doi: 10.1046/j.1369-6513.1999.00027.x.
    1. O'Connor AM. [2019-05-22]. User Manual-Measures of Decision/Choice Predisposition 1996 09/30/2017 cited 2017 September 30 .
    1. O'Connor AM. [2019-05-22]. User Manual- Stage of Decision Making 2000 (Modified 2003) 09/30/2017 cited 2017 September 30 .
    1. Bennett C, Graham ID, Kristjansson E, Kearing SA, Clay KF, O'Connor AM. Validation of a preparation for decision making scale. Patient Educ Couns. 2010 Jan;78(1):130–3. doi: 10.1016/j.pec.2009.05.012.
    1. Brehaut JC, O'Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, Feldman-Stewart D. Validation of a decision regret scale. Med Decis Making. 2003;23(4):281–92.
    1. O'Connor AM. [2019-05-22]. User Manuals Self-Efficacy 1995 .
    1. O'Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995;15(1):25–30.
    1. Baker J. [2019-08-11]. Brafton 2017 Content Marketing Benchmark Report
    1. Sinha CB, Bakshi N, Ross D, Krishnamurti L. From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea. PLoS One. 2018;13(6):e0199375. doi: 10.1371/journal.pone.0199375.
    1. Bakshi N, Sinha CB, Ross D, Khemani K, Loewenstein G, Krishnamurti L. Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease. PLoS One. 2017;12(7):e0178413. doi: 10.1371/journal.pone.0178413.
    1. Bischoff B. wwwspinutechcom/blog Internet. 2015. [2019-05-22]. 7 Website Analytics That Matter Most
    1. Tian H, Brimmer DJ, Lin JS, Tumpey AJ, Reeves WC. Web usage data as a means of evaluating public health messaging and outreach. J Med Internet Res. 2009;11(4):e52. doi: 10.2196/jmir.1278.
    1. Yu CH, Parsons JA, Mamdani M, Lebovic G, Hall S, Newton D, Shah BR, Bhattacharyya O, Laupacis A, Straus SE. A Web-based intervention to support self-management of patients with type 2 diabetes mellitus: effect on self-efficacy, self-care and diabetes distress. BMC Med Inform Decis Mak. 2014 Dec 14;14:117. doi: 10.1186/s12911-014-0117-3.
    1. Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R, Trevena L, Wu JHC. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1:CD001431. doi: 10.1002/14651858.CD001431.pub4.
    1. Witteman HO, Gavaruzzi T, Scherer LD, Pieterse AH, Fuhrel-Forbis A, Chipenda Dansokho S, Exe N, Kahn VC, Feldman-Stewart D, Col NF, Turgeon AF, Fagerlin A. Effects of Design Features of Explicit Values Clarification Methods: A Systematic Review. Med Decis Making. 2016 Aug;36(6):760–76. doi: 10.1177/0272989X16634085.
    1. Witteman HO, Scherer LD, Gavaruzzi T, Pieterse AH, Fuhrel-Forbis A, Chipenda DS, Exe N, Kahn VC, Feldman-Stewart D, Col NF, Turgeon AF, Fagerlin A. Design Features of Explicit Values Clarification Methods: A Systematic Review. Med Decis Making. 2016 May;36(4):453–71. doi: 10.1177/0272989X15626397.
    1. Jolles MP, Lee P, Javier JR. Shared decision-making and parental experiences with health services to meet their child's special health care needs: Racial and ethnic disparities. Patient Educ Couns. 2018 Oct;101(10):1753–1760. doi: 10.1016/j.pec.2018.05.022.
    1. Crosby LE, Walton A, Shook LM, Ware RE, Treadwell M, Saving KL, Britto M, Peugh J, McTate E, Oyeku S, Nwankwo C, Brinkman WB. Development of a Hydroxyurea Decision Aid for Parents of Children With Sickle Cell Anemia. J Pediatr Hematol Oncol. 2019 Jan;41(1):56–63. doi: 10.1097/MPH.0000000000001257.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit